ReShape Lifesciences Inc. (RSLS) NASDAQ
3.92
+0.72(+22.50%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.58M |
| Enterprise Value | -369,551 |
| P/E Ratio | -1.03 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 9.63 |
| Price/Book Ratio | 2.02 |
| Enterprise/Revenue | 3.11 |
| Enterprise/EBITDA | -0.77 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -9.85 |
| Operating Margin | -4.02 |
Management Effectiveness
| Return On Assets | -1.3 |
| Return On Equity | -3.02 |
Income Statement
| Revenue | 319,714 |
| Revenue/Share | 0.23 |
| Gross Profit | 218,771 |
| EBITDA | -10.34M |
| Net Income | -10.48M |
| Diluted EPS | 0 |
Balance Sheet
| Total Cash | 8.8M |
| Total Cash/Share | 1.49 |
| Total Debt | 22,548 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.27 |
| Book Value Per Share | 1.36 |
Price History
| 52-Week Change | -99.6 |
| 52-Week High | 1,212.99 |
| 52-Week Low | 2.8 |
| Moving Average 50 Days | 10.51 |
| Moving Average 200 Days | 187.03 |
Statistics
| Average Volume | 943,701 |
| Shares Outstanding | 596,490 |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | August 15, 2025 |
